{"text": ["FDA", "Moves", "to", "Make", "Life", "Easier", "for", "Generic", "Drug", "Companies"], "created_at": "2018-05-31 22:46:00"}
{"text": ["FDA", "Moves", "to", "Ease", "Way", "for", "Generic", "Drugmakers"], "created_at": "2018-05-31 19:51:00"}
{"text": ["ASCO", "Conference", "Preview:", "Here's", "What", "Biotech", "Investors", "Need", "to", "Watch"], "created_at": "2018-05-31 19:16:00"}
{"text": ["ASCO", "Conference", "Preview:", "Here's", "What", "Biotech", "Investors", "Need", "to", "Watch"], "created_at": "2018-05-31 19:16:00"}
{"text": ["How", "Novartis\u2019s", "Business", "Segments", "Did", "in", "Q1"], "created_at": "2018-05-31 18:50:02"}
{"text": ["Assessing", "GlaxoSmithKline\u2019s", "Quarterly", "Revenues"], "created_at": "2018-05-31 17:45:10"}
{"text": ["Analyzing", "Novartis\u2019s", "Revenue", "in", "Q1"], "created_at": "2018-05-31 17:20:10"}
{"text": ["A", "Look", "at", "GlaxoSmithKline\u2019s", "Valuation", "on", "May", "29"], "created_at": "2018-05-31 16:12:43"}
{"text": ["How", "Novartis\u2019s", "Valuation", "Compares"], "created_at": "2018-05-31 15:46:21"}
{"text": ["Outcome", "Health", "names", "4", "new", "board", "members"], "created_at": "2018-05-31 15:26:20"}
{"text": ["George", "Soros", "Bought", "This", "Clinical-Stage", "Biotech", "Stock.", "Should", "You?"], "created_at": "2018-05-31 15:10:49"}
{"text": ["George", "Soros", "Bought", "This", "Clinical-Stage", "Biotech", "Stock.", "Should", "You?"], "created_at": "2018-05-31 15:10:49"}
{"text": ["George", "Soros", "Bought", "This", "Clinical-Stage", "Biotech", "Stock.", "Should", "You?"], "created_at": "2018-05-31 13:32:00"}
{"text": ["The", "Swiss", "Stock", "Market", "Finished", "Lower", "After", "Late", "Sell-Off"], "created_at": "2018-05-31 12:14:00"}
{"text": ["The", "Swiss", "Stock", "Market", "Finished", "Lower", "After", "Late", "Sell-Off"], "created_at": "2018-05-31 12:14:00"}
